Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to cre... Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss. Mehr anzeigen
CAMBRIDGE, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based...
-REWRITE study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of KRRO-110 -First participant dosing anticipated in the first...
CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.66 | 5.35211267606 | 49.7 | 52.36 | 44.65 | 102286 | 47.33027703 | CS |
| 4 | -15.94 | -23.3382137628 | 68.3 | 76.79 | 44.65 | 124731 | 59.5326517 | CS |
| 12 | 1.45 | 2.84816342565 | 50.91 | 98 | 30.719 | 123681 | 59.66088273 | CS |
| 26 | 1.86 | 3.68316831683 | 50.5 | 98 | 30.005 | 93425 | 52.74572471 | CS |
| 52 | 16.45 | 45.8089668616 | 35.91 | 98 | 30.005 | 64905 | 54.28593383 | CS |
| 156 | 39.36 | 302.769230769 | 13 | 98 | 13 | 67556 | 53.05769576 | CS |
| 260 | 39.36 | 302.769230769 | 13 | 98 | 13 | 67556 | 53.05769576 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
